Fusenig, Norbert
Tumor Angiogenesis
1. Tumor Angiogenesis: from Bench to Bedside
Judah Folkman
2. Vasculogenesis and Angiogenesis in Development
Anne Eichmann, Karine Bouvrée, Luc Pardanaud
3. Guidance of Vascular and Neuronal Network Formation
Carmen Ruiz Almodovar, Serena Zacchigna, Monica Autiero, Peter Carmeliet
4. The Angiogenic Switch in Tumorigenesis
Andreas Wicki, Gerhard Christofori
5. Pathophysiology and Clinical Implications of Vascular Endothelial Growth Factor
Napoleone Ferrara
6. Regulation of Angiogenesis and Vascular Homeostasis Through the Angiopoietin / Tie System
Hellmut G. Augustin, Ulrike Fiedler
7. Eph Receptors and Ephrins: Role in Vascular Development and Tumor Angiogenesis
Dana M. Brantley-Sieders, Jin Chen
8. The Role of the Neuropilins and Their Associated Plexin Receptors in Tumor Angiogenesis and Tumor Progression
Gera Neufeld, Ofra Kessler
9. Platelet-derived Growth Factor: Impact on Physiological and Tumor Angiogenesis
Arne Östman, Christer Betsholtz
10. Hypoxia and Tumour Angiogenesis
M. Christiane Brahimi-Horn, Julie Laferrière, Nathalie Mazure, Jacques Pouyssegur
11. Hypoxia and Angiogenesis in Glioblastomas
Till Acker, Karl H. Plate
12. Endogenous Inhibitors of Angiogenesis
Malin Sund, Raghu Kalluri
13. Thrombospondins and Angiogenesis
Nathan V. Lee, M. Luisa Iruela-Arispe
14. Molecular and Cellular Aspects of Heparanase
Neta Ilan, Liat Fux, Michael Elkin, Israel Vlodavsky
15. Vessel Maturation and Perivascular Cells
Anne M. Goodwin, PatriciaA. D’Amore
16. Adhesion Molecules in the Vascular Cell Cross-Talk
Ugo Cavallaro
17. Homing and Differentiation of Endothelial Progenitor Cells
Carmen Urbich, Emmanouil Chavakis, Stefanie Dimmeler
18. Molecular Players in Lymphangiogenesis
Marja Lohela, Kari Alitalo
19. The Relationship Between Tumors and the Lymphatics: Consequences for Metastasis
Jonathan P. Sleeman
20. Inflammation and Angiogenesis: Innate Immune Cells as Modulators of Tumor Vascularization
MargaretaM. Mueller
21. Arteriovenous Malformation in Mice and Men
Nicole Revencu, Laurence Boon, Miikka Vikkula
22. Vascular Endothelial Growth Factor Antibodies for Anti-Angiogenic Therapy
Hans-Peter Gerber, Megan E. Baldwin, Farbod Shojaei
23. Vascular Endothelial Growth Factor
Stephen R. Wedge, Juliane M. Jürgensmeier
24. Vascular Endothelial Growth Factor Receptor Antibodies for Anti-Angiogenic Therapy
Peter Bohlen, Zhenping Zhu, Daniel J. Hicklin
25. Angiopoietin-2 Antagonists for Anti-Angiogenic Therapy
Paul E. Hughes, Anthony Polverino, Jonathan D. Oliner, Richard L. Kendall
26. Anti-Angiogenic Therapy with Thrombospondins
Jack Lawler
27. The Use of Orthotopic Models to Validate Antivascular Therapies for Cancer
Robert R. Langley, Sun-Jin Kim, Isaiah J. Fidler
28. Vascular Tumor Targeting
Dragan Grabulovski, Dario Neri
29. Molecular Imaging of Targets and Therapeutics in Tumour Angiogenesis
James P. B. O’Connor, Daniela D. Rosa, Alan Jackson, Gordon C. Jayson
30. Imaging of Tumor Angiogenesis and Antiangiogenesis
Fabian Kiessling, Martin Krix
31. Visualization of Microcirculation and Anti-Angiogenic Tumor Therapy
Marcus Czabanka, Peter Vajkoczy
32. Cellular Actions of Angiogenesis Inhibitors on Blood Vessels
Peter Baluk, Beverly L. Falcón, Hiroya Hashizume, Barbara Sennino, Donald M. McDonald
33. Antiangiogenic Therapy for Normalization of Tumor Vasculature and Microenvironment
Rakesh K. Jain, Dan G. Duda
34. Metronomic Antiangiogenic Chemotherapy: Questions and Answers
Robert S. Kerbel, Urban Emmenegger, Shan Man, Raquel Munoz, Francesco Bertolini, Yuval Shared
35. The Development of Avastin
Robert Mass
36. Clinical Development of Sorafenib (BAY 43–9006) VEGFR and RAF Inhibitor
Dimitris Voliotis, J. Dumas
37. Clinical Development of the VEGFR Signalling Inhibitor AZD2171
Joachim Drevs, Clemens Unger
38. Clinical Development of Sunitinib Malate
Isan Chen, Carlo Bello, Zuleima Aguilar
39. The EGF(R) and VEGF(R) Pathways as Combined Targets for Anti-Angiogenesis Trials in Cancer Therapy
Klaas Hoekman, Hester Cruijsen, Giuseppe Giaccone
40. Imaging the Effect of Anti-Angiogenic Tumor Therapy in Clinical Studies
Bruno Morgan, Mark A. Horsfield
41. Vandetanib (ZACTIMA™; ZD6474): Preclinical and Clinical Development
Alan Barge, Anderson J. Ryan
42. Integrins: Targets for Anti-Angiogenic Therapy
Oliver Kisker
43. Thalidomide in Multiple Myeloma
Thomas M. Moehler, Jens Hillengass, Axel Glasmacher, Hartmut Goldschmidt
44. Surrogate Markers of Angiogenesis
Valentina Raia, Patrizia Mancuso, Francesco Bertolini
45. Vascular Disrupting Agents in Cancer Therapy
Gillian M. Tozer, Chryso Kanthou, David J. Chaplin
DRM-restrictions
Printing: not available
Clipboard copying: not available
Avainsanat: MEDICAL / Public Health MED078000
- Tekijä(t)
- Fusenig, Norbert
- Marmé, Dieter
- Julkaisija
- Springer
- Julkaisuvuosi
- 2008
- Kieli
- en
- Painos
- 1
- Kategoria
- Terveys, kauneus, muoti
- Tiedostomuoto
- E-kirja
- eISBN (PDF)
- 9783540331773